Cognition Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
Portfolio Pulse from Avi Kapoor
Insiders at Blue Star Foods, Ekso Bionics, and Cognition Therapeutics have recently made significant stock purchases, signaling potential confidence in their companies' futures. Blue Star Foods signed a master service agreement with a seafood provider, Ekso Bionics reported mixed Q4 results, and Cognition Therapeutics closed an $11.5 million public stock offering.
March 15, 2024 | 11:13 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Ekso Bionics Director Corinna Lathan bought 13,733 shares amid mixed Q4 financial results, suggesting a belief in long-term value.
The insider purchase at Ekso Bionics, despite mixed Q4 results, might indicate insider confidence in the company's recovery and growth potential, but the mixed financial results introduce uncertainty, leading to a neutral short-term impact.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Blue Star Foods Director Nubar Herian purchased 219,611 shares, signaling insider confidence following a new service agreement.
The insider purchase combined with the recent service agreement could indicate a positive outlook for Blue Star Foods, potentially leading to a short-term positive impact on the stock.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Cognition Therapeutics CEO and President Lisa Ricciardi acquired 5,700 shares, following an $11.5 million public offering, showing strong insider belief in the company's direction.
The insider purchase by Cognition Therapeutics' CEO and President after a significant public offering suggests a high level of confidence in the company's future prospects, likely leading to a positive short-term impact on the stock.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90